Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...